Posters
ADVANCES IN MS
61 How many scans is enough? Predicting resolving power in 2DMS experiments
Anna Cordiner (University of York)
________________________________________________
62 Mass spectrometry without chromatography: Analysis of mixtures by collision induced dissociation without precursor isolation
Steven Wright (Verdel Instruments)
________________________________________________
63 Distinctive fragmentations in EI mass spectra of orthogonally protected sulphonamides and their isomeric rearrangement products
Amie Saidykhan (University of Bradford)
________________________________________________
64 Development of helium-free direct analysis in real time mass spectrometry and application to food authenticity
Hannah Tate (University of York)
AWAITING PDF
________________________________________________
65 SPME, ASAP-MS and Me: a sensitive and rapid approach to pesticide analysis
Dara Lorianne Pierre (University of Surrey)
________________________________________________
66 High throughput screening of post-translational modifications across antibody candidates to inform machine learning
Clare Noon (UCB)
________________________________________________
67 Novel nano-electrospray ion source for charge detection mass spectrometry
Rob Lewis (Waters Corporation)
AWAITING PDF
________________________________________________
68 The design and characterisation of a new CDMS instrument for the analysis of megadalton-sized molecules
David Bruton (Waters Corporation)
AWAITING PDF
________________________________________________
AMBIENT & IMAGING MS
69 Optimisation of nanospray desorption electrospray ionisation (nano-DESI) probes for native ambient mass spectrometry imaging workflows
Jack Roberts (Rosalind Frankling Institution)
________________________________________________
70 A versatile, high-throughput robotic platform for multimodal sample introduction to a SICRIT ion source
Barry Smith (University of Liverpool)
AWAITING PDF
________________________________________________
71 High-resolution microscope-mode secondary ion mass spectrometry imaging
Yuting Su (University of Oxford)
________________________________________________
72 A novel embedding-free approach to ocular cryosection preparation for native ambient mass spectrometry
Peter Hughes (Rosalind Franklin Institute)
________________________________________________
73 Paper-arrow mass spectrometry for rapid cortisone analysis from salivary microsamples
Tung-Ting Sham (University of Liverpool)
AWAITING PDF
________________________________________________
74 Rapid detection of drugs in E-cigarettes using ambient ionisation mass spectrometry
Adam Haworth-Duff (University of Liverpool)
AWAITING PDF
________________________________________________
75 Employing EDC for semi-targeted MSI with SELECT SERIES MRT mass spectrometer and DESI XS
Ross Chawner (Waters Corporation)
________________________________________________
76 Echo-DESI-MS for high-throughput screening of biotransformations
Rachel Smith (University of Manchester)
________________________________________________
77 High resolution DESI imaging single cell analysis
Joanne Ballantyne (Waters Corporation)
AWAITING PDF
________________________________________________
78 Evaluation of perfused tissue for analysis of intact proteoforms by native ambient mass spectrometry (NAMS)
Hadar Ash (University of Birmingham)
________________________________________________
79 Evaluating ASAP-MS for rapid detection of sports prohibited substances: optimising workflows using SpectralWorks AnalyzerPro XD
Liam Heaney (Loughborough University)
________________________________________________
BIOPHARMACEUTICALS
80 Application of high-resolution mass spectrometry workflows to characterise biopharmaceuticals and impurities
Tomas Adomavicius (Sygnature Discovery)
________________________________________________
81 State-of-the-art mass spectrometry characterisation of adeno-associated virus (AAV)
Lauren Tomlinson (Pharmaron Biologics Ltd)
________________________________________________
82 Improving quantitative sensitivity for peptide analysis in plasma using a novel QTOF mass spectrometer
Tom Ruane (SCIEX)
________________________________________________
83 Proteoform specific microheterogeneity assessment of biopharmaceuticals using the Orbitrap Ascend Biopharma Edition tribrid mass spectrometer
Jonathan Bones (National Institute for Bioprocessing Research and Training)
________________________________________________
84 Host cell protein analysis across innovator monoclonal antibody-based protein therapeutics using the Orbitrap Astral
Josh Smith (National Institute for Bioprocessing Research and Training)
AWAITING PDF
________________________________________________
85 Calibration of charge detection MS instruments
Keith Richardson (Waters Corporation)
AWAITING PDF
________________________________________________
86 Assessment of resolution and instrument type on the assessment of oligonucleotide impurities
Rachelle Black (AstraZeneca)
AWAITING PDF
________________________________________________
87 Characterisation of polysorbates in biopharmaceutical drug products using liquid chromatography mass spectrometry
Will Burkitt (UCB)
________________________________________________
88 Top down CID MS/MS and ETD MS/MS analysis and characterisation of TryBe molecules
Sophie Lellman (UCB)
AWAITING PDF
________________________________________________
89 Ligand:antibody affinity chromatography coupled to mass spectrometry
Nisha Patel (UCB)
________________________________________________
90 Rapid online buffer exchange with the DynaChip platform for complex native biological analysis
Suraj Dhungana (Andson Biotech)
________________________________________________
CLINICAL & FORENSIC
91 Identification of cancer biomarkers in human breath utilising TD-GC-MS
Valerio Converso (Imperial College London)
________________________________________________
92 Delivering real-time therapeutic drug monitoring of β-lactams using LC-MS/MS: insights from the TDM-TIME study
Jake Lain (Manchester University NHS Foundation Trust)
________________________________________________
93 Advancing precision medicine with mass spectrometry: The Centre for Precision Approaches to Combatting Antimicrobial Resistance
Kamila Schmidt (University of Manchester)
________________________________________________
94 A new plasma N-glycomics-based strategy for the diagnosis of congenital disorders of glycosylation
Alan Riberio Mol (Universidade de Brasilia)
AWAITING PDF
________________________________________________
95 Multimodal analytical approach applied to whisky labels for authenticity determination
Veronika Tibljas (Sheffield Hallam University)
________________________________________________
96 Identifying the amyloid fibril protein in patients with amyloid of an unknown type
Metkel Tsegay (University College London)
________________________________________________
97 Integrated tissue and plasma multi-omics profiling reveals distinct T2D signatures in patients undergoing CABG
Scarlett Manley (University of Leicester)
________________________________________________
98 Determination of the salivary steroid profile using mass spectrometry
Mariyam Mariyam (University of Birmingham)
________________________________________________
99 Combining DART ionization and trapped ion mobility QTOF-mass spectrometry for the analysis of controlled substances
Stephen Brookes (Bruker)
________________________________________________
EARTH, ENVIRONMENT & FOOD
100 Understanding fluoropolymer degradation in fuel cells through mass spectrometry*
Zoe McShane (Johnson Matthey)
________________________________________________
101 Investigation of atmospheric transfer of ‘forever chemicals’ from sewage using targeted and non-targeted HRMS
Jishnu Pandamkulangara Kizhakkethil (Coventry University)
AWAITING PDF
________________________________________________
102 Comparison of hydrophilic-lipophilic balanced and weak anion exchange SPE for trapping airborne per/polyfluoroalkyl substances*
Amoluck Eluri (Deakin University)
AWAITING PDF
________________________________________________
103 PFAS/emerging contaminants leveraging the technique LC-VIP HESI-TIMS-HRMS and comprehensive untargeted workflows
Erik van Balderen (Bruker)
AWAITING PDF
________________________________________________
HDX & COVALENT LABELLING
104 Quantum-induced structural signalling in avian cryptochrome 4 revealed by HDX-MS
Monika Kish (University of Exeter)
________________________________________________
105 Higher order structure characterization of ADCs using hydrogen-deuterium exchange mass spectrometry (HDX-MS)
Denis Calnan (ThermoFisher Scientific)
AWAITING PDF
________________________________________________
106 Developing traceable multi-component test materials for the validation of PFAS LC-MS methods: The EURAMET ‘ScreenFood’
Christopher McElroy (LGC Group)
________________________________________________
ION MOBILITY MS
107 Integrating DT-IMS with compact mass spectrometry for field-deployable detection of drugs and explosives
Mohammed Al Saud (University of Liverpool)
________________________________________________
108 Differential mobility analyser (DMA) coupled with pixelated ion detector for illicit drug analysis in mixtures
Cedric Boisdon (University of Liverpool)
AWAITING PDF
________________________________________________
109 Characterisation of biomolecules by ion mobility-mass spectrometry and gas phase infrared spectroscopy
Caitlin Walton-Doyle (Freie Universität Berlin)
________________________________________________
110 Bridging the gap between free-molecular and continuum flow regimes in ion mobility spectrometry of nanoparticles
Kacper Kulikowski (Waters Corporation)
________________________________________________
LIFE SCIENCES
111 When one size doesn’t fit all: LC-MS in a multi-project facility
Marina-Alexandra Machidon (University of Manchester)
________________________________________________
METABOLOMICS & LIPIDOMICS
112 Development of an LC-MS/MS method for the combined quantification of oxysterols and bile acids
Martin Roumain (UCLouvain)
________________________________________________
113 Automated identification of verapamil metabolites using KNIME: comparative analysis in human, rat, and guinea pig
Nouf Alourfi (King Abdulaziz University)
________________________________________________
114 Secondary metabolites of endophytic Hypoxylon rubiginosum isolated from Fucus vesiculosus seaweed by using spectral-based metabolomics
Fadiah Almutairi (University of Strathclyde)
________________________________________________
115 Using ion mobility mass spectrometry for structural characterisation of lipids to advance Parkinson’s Disease diagnostics
Lea van Dissel (University of Manchester) Winner of the Bordoli Prize for best ECS poster (Sponsored by Waters)
________________________________________________
116 A novel cation-exchange chromatography-MS/MS method for metabolite and metal ion analysis in biological samples
Rachel Williams (University of Oxford)
________________________________________________
117 Characterisation of surfactant phospholipid synthesis and metabolism in mice models of acute lung injury
Siona Silveira (University of Southampton)
________________________________________________
118 A targeted LC-MS/MS lipidomics panel developed for use in clinical assays for aspirin resistance patients
Aldred Charlesworth (University of Leicester)
________________________________________________
119 Accelerating lipidomics: integrating microsampling devices with rapid microbore metabolic profiling (RaMMP) for UPLC-MS analysis
Ana Sanchez Lorenzo (Imperial College London)
________________________________________________
MS IN STRUCTURAL BIOLOGY
120 Assembly pathway of bacterial protein nanocages
Thomas Ballinger (University of Edinburgh)
________________________________________________
121 Charge detection mass spectrometry analysis of thermally activated native protein complexes*
Anisha Haris (Waters Corporation)
AWAITING PDF
________________________________________________
122 DynaChip online buffer exchange and desalting coupled to CD-MS for the analysis of large biologics
Mason Chilmonczyk (Andson Biotech)
AWAITING PDF
________________________________________________
123 Understanding oligonucleotides: structural insights into the thrombin-binding aptamer and 38-GC using ion mobility and UVPD
Francesca O Bellingeri (University of Leeds)
________________________________________________
124 Adjustable source pressure regulation improves the transmission of protein complexes on Orbitrap Tribrid mass spectrometer*
Sherzod Nazarov (University of Birmingham)
________________________________________________
125 The power of combining mutagenesis, mass spectrometry, and molecular dynamic simulations to decode nanobody stability*
Valentina Faustinelli (LGC Group)
________________________________________________
PROTEOMICS
126 Are Solid Particles Ready for Prime-Time Proteomics?
Eduardo Shigueo Kitano (Rosalind Franklin Institute)
________________________________________________
127 Novel recombinant chymotrypsin: a superior complementary protease to trypsin for proteomics
Jon Ditcham (University College London)
AWAITING PDF
________________________________________________
128 Standard LC-MS workflows using a single deep learning model
Shabaz Mohammed (Rosalind Franklin Institute)
AWAITING PDF
________________________________________________
129 Investigating chemical modifications of pollen proteins on exposure to air pollutants using non-targeted MS analysis *
Dimple Pathania (Deakin University)
AWAITING PDF
________________________________________________
130 Optimising mass spectrometry to study the proteoform changes in VPS35-D620N protein mutation of Parkinson’s disease
Yuko Lam (University of Dundee)
________________________________________________
131 Ultra-sensitive quantitation and rapid method development for targeted immunopeptidomics using the Stellar Mass Spectrometer
Christopher Knowles (ThermoFisher Scientific)
AWAITING PDF
________________________________________________
132 Label-free quantitative proteomics with high precision and accuracy, driven by ultra-high-sensitivity MS/MS
Daniel Parnaby (SCIEX)
133 Keep an i-on kynurenine: proteomic profiling of WT and KMO⁻/⁻ Drosophila melanogaster via Evosep–timsTOF workflow
Muzammil Khomusi (University of Leicester)
________________________________________________
134 Reinventing chymotrypsin: a novel recombinant analog for accurate and reliable peptide mapping of biotherapeutic proteins
Chris Moffat (Promega)
________________________________________________
SMALL MOLECULES & PHARMACEUTICALS
135 Quantitative end-of-reaction monitoring in pharmaceutical drug development using ASAP-MS
Catherine Welsh (AstraZeneca)
________________________________________________
136 A high-throughput native mass spectrometry-based platform for the screening and characterisation of small-molecule drugs
Aisha Ben-Younis (OMass Therapeutics)
________________________________________________
137 From method to mindset: using cortisol LC-MS/MS as a structured training platform
Paul Sampson (University of Leicester)
________________________________________________
138 Advanced data analysis of peptide LC-MS spectra through in silico fragmentation
Michael Sutherland (Advanced Chemistry Department UK Ltd)
________________________________________________
139 Evaluating ethnic differences in antihypertensive drug responses in the AIM-HY cohort using LC-MS/MS analyses
Ammar Akram (University of Leicester)
________________________________________________
140 Bridging quantification and structural resolution in lipidomics: a dual-derivatization approach based on GC-MS and LC-MS/MS
Yicen Yue (University of Liverpool)
________________________________________________
141 Development of a gas chromatography mass spectrometry method for urinary oestrogen profiling
Joshua Bain (University of Birmingham)
________________________________________________
142 Transforming quantitative sensitivity for small molecule analysis using a high-resolution workflow
Iain Mayer (SCIEX)
AWAITING PDF
________________________________________________
143 Combining high-throughput affinity selection mass spectrometry-based platform and native-MS to discover and characterize β1AR ligands
Juliana Maria De Lima (OMass Therapeutics)
AWAITING PDF
________________________________________________
144 Maximising confidence in nitrosamine analysis: strategies to prevent false positives and negatives in LC-MS
Nathanael Page (Resolian)
________________________________________________